XML 26 R17.htm IDEA: XBRL DOCUMENT
v3.23.3

Summary of Significant Accounting Policies (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2023
Accounting Policies [Abstract] |
Schedule of Earnings Per Share Anti-diluted | The following financial instruments were not included in the diluted loss per share calculation as of September 30, 2023 and 2022 because their effect was anti-dilutive: Schedule of Earnings Per Share Anti-diluted
|  | 2023 |  |  | 2022 |
|  | As of September 30, |
|  | 2023 |  |  | 2022 |
Warrants to purchase common stock |  |  | 712,500 |  |  |  | 945,837 |
Options |  |  | 1,150,000 |  |  |  | 1,285,000 |
Non-vested restricted stock awards units |  |  | 1,631,399 |  |  |  | 1,612,350 |
Total |  |  | 3,493,899 |  |  |  | 3,843,187 |
Anti-dilutive securities |  |  | 3,493,899 |  |  |  | 3,843,187 |

X
- References No definition available. + Details
Name: | us-gaap_AccountingPoliciesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482662/260-10-50-1 + Details
Name: | us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration